News

Findings from the largest genetic study of PTSD to date could help explain why only some people develop the condition after experiencing trauma.

Cedars-Sinai investigators have discovered how brain cells responsible for working memory–the type required to remember a phone number long enough to dial it–coordinate intentional focus and short-term storage of information.

Salk scientists observe cannabinol's neuroprotective properties in fruit flies and identify cannabinol analogs that could serve as promising future therapeutics for traumatic brain injury, Alzheimer's, and Parkinson's.

Antipsychotic use in people with dementia is associated with elevated risks of a wide range of serious adverse outcomes including stroke, blood clots, heart attack, heart failure, fracture, pneumonia, and acute kidney injury, compared with non-use.

University of Cambridge researchers have harnessed the power of artificial intelligence (AI) to speed up the screening of new drugs to treat Parkinson’s disease.

A group of researchers at University of California San Diego School of Medicine led an investigation that offers new insight into the development of the human forebrain.

A new study revealed that Alzheimer's disease starts earlier and progresses faster in people with Down syndrome, which could have important implications for their treatment and care.

A new study from Van Andel Institute scientists offers a first look into the complex molecular changes that occur in brain cells with Lewy bodies, which are key pathological hallmarks of Parkinson’s disease and some dementias.

Researchers observed that adolescent rats fed on a junk food diet had lower levels of key neurotransmitters associated with memory than their snackless counterparts.

In a new study, researchers have identified a novel mechanism potentially connected to the early stages of Alzheimer's disease. They found a fragment of the amyloid precursor protein (APP) disrupts communication between cellular compartments.